MAPK mutations are not frequently observed in breast cancer, a survey of commonly used breast cancer cell lines reported that 25% (10) of cell lines surveyed contained mutations in KRAS, BRAF, HRAS, or NRAS, with two cell lines displaying more than one mutation [41]. This evidence concerns the gene NRAS and breast cancer.